fimH gene cloning, of Escherichia coli uropathogen and examination of its subsequence diversity

Escherichia coli uropathogen is the most prevalent pathogen separated from urinary tract that often is originated from intestinal flora of the own person. Urinary tract infection is one of the most prevalent infectious diseases in Human. Whereas binding stage has an important role in bacteria colonization and then the infection is created، one of the most important strategies for inhibiting the infection is inhibiting the bacterial binding. As fimH protein is acting as adhesion it could be an appropriate candidate for producingvaccine. First، genomic DNA of Escherichia coli bacteria extracted from strain 35218 ATCC. Upon designing primer for fimH gene، the PCR reaction has been applied with Taq DNA Polymerase and then pfu DNA polymerase enzymes. pBluescript (SK-) plasmid has been applied for cloning the product of PCR. Using ClustalW and MEGA4 software، the subsequence was alignmented with the gene subsequence existing in gene bank and its gene diversity was examined. After sequencing the cloned fimH gene using ClustalW and MEGA4 software، the result of this subsequence were alignmented with the subsequence of Escherichia coli containing fimH gene existing in gene bank and based on this alignment، N terminal on the protein surface and DNA are protected. N terminal domain of fimH gene is a conserved sequence among clinical isolates and it could be used for designing a vaccine against urinary tract infection.